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Studies from our group and others have shown that in vitro somite myogenesis is regulated by neural tube and notochord
factors including Wnt, Sonic hedgehog (Shh), and basic fibroblast growth factor (bFGF) together with transforming growth
factor-b1 (TGF-b1). In this study we report that insulin and insulin-like growth factors I and II (IGF-I and -II) also promote
myogenesis in explant cultures containing single somites or somite-sized pieces of segmental plate mesoderm from 2-day
(stage 10–14) chicken embryos and that the combination of insulin/IGFs with bFGF plus TGF-b1 promotes even higher
levels of myogenesis. We also found that Shh promotes myogenesis in this in vitro system and that Shh interacts
synergistically with insulin/IGFs to promote high levels of myogenesis. RT-PCR analysis detected insulin, IGF-II, insulin
receptor, and IGF receptor mRNAs in both the neural tube and the somites, whereas IGF-I transcripts were detected in
entire embryos but not in the neural tube or somites. Treatment of somite–neural tube cocultures with anti-insulin,
anti-IGF-II, anti-insulin receptor, or anti-IGF receptor blocking antibodies caused a significant decrease in myogenesis.
These results are consistent with the hypothesis that systemic IGF-I as well as insulin and IGF-II secreted by the neural
tube act as additional early myogenic signals during embryogenesis. Further studies indicate that insulin, IGFs, bFGF, and
Shh also stimulate somite cell proliferation and influence apoptosis. © 2000 Academic Press
Key Words: somite; myogenesis; muscle; neural tube; insulin-like growth factors (IGFs); IGF receptors; Sonic hedgehog
(Shh); fibroblast growth factor; TGF-b1; apoptosis.a
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eINTRODUCTION
Somite myogenesis is both positively and negatively
regulated by factors produced by the neural tube, noto-
chord, ectoderm, and lateral plate mesoderm. Positive sig-
nals include Wnt family members and Sonic hedgehog (Shh)
(Christ et al., 1992; Buffinger and Stockdale, 1994; Mu¨nster-
berg et al., 1995a,b; Stern et al., 1995; Cossu et al., 1996;
Fan et al., 1997; Capdevila et al., 1998; Borycki et al., 1998,
1999; Marcelle et al., 1997, 1999). In contrast, bone mor-
phogenetic protein (BMP4) inhibits myogenesis (Pourquie´
et al., 1995, 1996) by repressing expression of the muscle
determination factors MyoD and Myf5 (Reshef et al., 1998),
1 Current address: Department of Medical Biochemistry, Univer-
sity of Oulu, Box 5000, FIN-90014, Oulu, Finland.
2 To whom correspondence should be addressed at the Depart-
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All rights of reproduction in any form reserved.while noggin counteracts BMP4 repression (Hirsinger et al.,
1997). Interestingly, Shh and Wnt signals can also compete
with each other in the specification of presomitic meso-
derm to become sclerotome or dermamyotome (Lee et al.,
2000). Several other factors, when acting combinatorially or
synergistically, can also induce/promote somite myogen-
esis in vitro, e.g., Stern et al. (1997) reported that basic
fibroblast growth factor (bFGF) 1 transforming growth
factor-b1 (TGF-b1) stimulated high levels of myogenesis in
single somite assay system; however, the full spectrum of
actors and the mechanisms by which they affect somite
yogenesis are unknown.
In addition to direct myogenic “inducing/promoting”
ffects, Marcelle et al. (1999) have reported that Shh is
capable of maintaining but not inducing somite MyoD
expression, Teillet et al. (1998) have shown that Shh en-
hances myogenic cell survival, and Cann et al. (1999) have
reported that Shh mimics effects of the ventral neural tube
by increasing myogenic progenitor cell proliferation, inhib-
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190 Pirskanen, Kiefer, and Hauschkaiting apoptosis, and enhancing the number of primary
muscle fibers expressing slow myosin heavy chain. In
contrast, Borycki et al. (1999) reported that Shh is required
or the survival of sclerotomal cells, but not for the survival
r proliferation of epaxial myogenic progenitors. Finally,
any studies indicate that the end results of inductive
ignals depend upon the sequence of exposure, concentra-
ions of positive and negative signals, and somite stage
Hirsinger et al., 1997; Reshef et al., 1998; Williams and
rdahl, 1997). Taken together, these studies imply that the
rderly induction of somite myogenesis in vivo entails a
omplex temporal and quantitative interplay between mul-
iple positive and negative signals. This further implies that
ignaling molecules not yet considered “direct” compo-
ents of early myogenic development could influence these
rocesses.
Insulin and insulin-like growth factors I and II (IGF-I and
GF-II) are hormonal peptides with overlapping biological
ffects on muscle (Cohick and Clemmons, 1993; Florini et
l., 1996). Expression of insulin and IGFs and their receptors
as been found in chicken embryos as early as day 1
Perez-Villamil et al., 1994; Holzenberger et al., 1996;
orales et al., 1997), and effects of these factors on neural
evelopment have been observed in day 2 embryos (de la
osa et al., 1994; De Pablo and de la Rosa, 1995). IGF-I is
resent in egg yolk (Scavo et al., 1989) and it is thought that
nsulin and the IGFs are present systemically at these early
tages. In addition to stimulating myoblast proliferation,
hese factors stimulate many anabolic processes in differ-
ntiated skeletal muscle, and all three members of the IGF
amily also potentiate muscle cell terminal differentiation
n vitro. The importance of IGF-I for embryonal muscle
evelopment has also been demonstrated by IGF-I-
nockout experiments (Baker et al., 1993; Powell-Braxton
t al., 1993). In addition to their significantly smaller size,
GF-I-deficient mice exhibit a severe muscular dystrophy.
Insulin and IGF-I receptors are heterotetrameric trans-
embrane proteins containing an intracellular ATP-
inding site and a tyrosine cluster which requires phosphor-
lation for activation of kinase activity (for review, see
lorini et al., 1996). After activation, the receptors can
interact with intermediate signaling proteins, e.g., insulin
receptor substrate-1 and Src homology containing protein,
leading to activation of protein kinase pathways. The IGF-II
receptor is identical to the cation-independent mannose
6-phosphate receptor (Florini et al., 1996; Zhou et al., 1995).
It is not a signal transducer and has been found to serve
primarily as a sink for excess IGF-II. Thus, the biological
actions of both IGF-I and IGF-II are mediated mainly by
IGF-I receptor.
To better understand the contribution of insulin and IGFs
to early myogenesis we investigated their function using an
in vitro single-somite assay (Stern and Hauschka, 1995). In
this system, somites I–III/IV from stage 13/14 chick em-
bryos exhibit no differentiated muscle cells when cultured
alone and are thus operationally defined as “uncommitted”
with respect to myogenesis. In contrast, somites V–VIII,
Copyright © 2000 by Academic Press. All rightwhile not containing myosin heavy chain (MyHC)-positive
cells in vivo, are able to form such cells after 3 days of in
vitro culture and are thus operationally defined as “com-
mitted” to the myogenic lineage. When uncommitted
somites are cultured with neural tube, notochord, Wnt-1-
producing fibroblasts, or FGF 1 TGF-b1, some cells become
MyHC-positive and are thus operationally defined as hav-
ing been “induced” to become myogenic (Stern and
Hauschka, 1995; Stern et al., 1995, 1997). It is critical to
emphasize that it is not known how far along a hypothetical
myogenic developmental pathway the cells in uncommit-
ted somites have progressed at the time of somite removal
from the embryo. When dissociated, some somite/
segmental plate and even epiblast cells form muscle with-
out needing exposure to the neural tube (George-Weinstein
et al., 1994, 1996), and RT-PCR assays detect both Myf5 and
MyoD in somites I–III (Mu¨nsterberg and Lassar, 1995b;
Kiefer and Hauschka, unpublished); but despite prior ex-
pression of these myogenic factors, cells in intact uncom-
mitted somites are unable to proceed to terminal differen-
tiation in vitro without exposure to additional “inductive”
stimuli. These can be provided either by coculture with the
neural tube/notochord or by addition of defined factors.
In the present study we used a single-somite assay
system to determine whether insulin and IGFs induce/
promote myogenesis in uncommitted somites and if they
stimulate myogenesis in somites containing cells already
committed to myogenesis. We demonstrate that, in the
absence of other known inducing factors, insulin, IGF-I,
and IGF-II induce as well as stimulate additional somite
myogenesis in a dose-dependent manner. Furthermore,
mRNAs for insulin, IGF-II, and insulin and IGF receptors
are found in the neural tube and in the paraxial meso-
derm, and IGF-I is expressed systemically. The hypoth-
esis that insulin and IGFs are involved in the normal
neural tube-mediated induction of somite myogenesis is
further supported by the finding that anti-insulin and
anti-IGF-II blocking antibodies inhibit neural tube-
induced myogenesis. Thus insulin and the IGFs should be
added to the growing list of soluble factors involved in
early aspects of somite myogenesis. Our studies also
show that insulin and IGFs function synergistically with
other myogenic inducing factors including bFGF 1
TGF-b1 and Shh. Two aspects of IGFs’ and Shh’s positive
effects on somite myogenesis in vitro may involve stimu-
lating cell proliferation and inhibiting cell death.
MATERIALS AND METHODS
Dissections. White Leghorn chicken eggs (H and N Interna-
tional) were incubated in a 38°C forced-draft incubator at 100%
humidity for 2 days. Stage 10–11 and 13–14 embryos (Hamburger
and Hamilton, 1951) were used for dissections. Tissues were
dissected as previously described (Stern and Hauschka, 1995).
Somites I–III were obtained from both sets of stages, whereas
somite IV was obtained only from embryos of stage 13 and younger.
This was necessary because at stage 14 somite pair IV contains
s of reproduction in any form reserved.
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191IGF–Shh Synergy in Somite Myogenesissome cells which are capable of undergoing myogenesis in vitro
without further neural tube signals (Stern and Hauschka, 1995). In
experiments employing somites from embryos as old as stage 14,
the somite numbers and stages are thus indicated as “somites
I–III/IV from stages 13–14.” In experiments designed to analyze the
behavior of somites containing many cells already committed to
myogenesis, somites V–VIII were dissected from stage 10–11 and
13–14 embryos. In studies designed to analyze the behavior of
presomitic cells, segmental plates were dissected from stage 10–11
embryos and cut into caudal and rostral halves and each half was
then cut into 4 somite-sized pieces. From stage 13–14 embryos,
segmental plates were cut into caudal, medial, and rostral regions.
Caudal and rostral regions were then cut into 4 somite-sized pieces.
Neural tube was dissected from between the rostral half of the
segmental plate and somite VIII from embryos of the same stages.
It was then cut transversely into 10 equal pieces. Previous studies
had indicated no differences in the myogenic inducing activity
between rostral and caudal neural tube segments from these
embryonic stages (Stern et al., 1995).
Tissue culture. The dissected explants were transferred into
he centers of gelatin-coated 96-well tissue culture plates con-
aining 200 ml of culture medium. Basal somite medium (BSM)
consisted of 99% Ham’s F10C nutrient medium (Ham’s F10 with
Ca21 adjusted to 1.26 mM) plus 30 nM sodium selenate (Sigma),
00 mM putrescine (Calbiochem), 0.1 mg/ml chick transferrin
(Sigma; conalbumin), and antibiotics (60 mg/ml gentamicin and
250 ng/ml Fungizone (Life Technologies)), plus 1% chick embryo
extract (CEE) (Konigsberg, 1968). Since CEE contains many
unknown components as well as some of the defined factors
being tested, e.g., bFGF (Linkhart et al., 1981; Seed et al., 1988),
certain studies were also performed in the absence of CEE (Fig. 4,
Table 2) so that interpretations could be made without the
ambiguity of unknown CEE components. Defined factors insu-
lin, IGF-I, IGF-II, bFGF, TGF-b1, and Shh were added to BSM as
pecified in the text. Recombinant human IGF-I and IGF-II were
urchased from Sigma, and bovine insulin was obtained from
ollaborative Biomedical. Human recombinant bFGF and acid-
ctivated human recombinant TGF-b1 were kindly provided by
Bristol–Myers Squibb. Shh-conditioned medium (;100 nM) was
produced in COS cells transfected with pShh (Roelink et al.,
1995). After 72 h, cultures were fixed and immunohistochemis-
try was performed as described below.
Neutralizing antibody studies. In antibody neutralization
studies, neural tubes from the same stages as the tested somites
were cut into somite-sized pieces, transferred to 96-well tissue
culture plates, and cultured in contact with single somites.
Neutralizing antisera were added to BSM as described in the text
and figure legends: goat anti-IGF-I and anti-IGF-II antibodies
(R&D Systems), rabbit anti-insulin receptor and sheep anti-
insulin antibodies (Biodesign International), and anti-IGF recep-
tor monoclonal antibody (Santa Cruz Biotechnology, Inc.). As
controls, normal rabbit and normal goat IgGs (R&D Systems)
were used in amounts equivalent to those of the neutralizing
antibodies.
Cell number, cell proliferation (S phase), and cell death assays.
Somites I–IV from stage 10–11 embryos were cultured in BSM with
various growth factors for 3 days. Explants were then trypsinized in
25 ml and cells were counted in a hemacytometer. To study growth
factor effects on proliferation, BrdU was added to the medium of
23-h cultures at a final concentration of 100 mM for 1 h. In other
tudies, cultures were labeled with BrdU (10 mM) for 24 h startingat 24 h in order to assess the total percentage of replicating cells.
Copyright © 2000 by Academic Press. All rightThe cultures were then fixed in 4% (w/v) paraformaldehyde and
BrdU-substituted DNA was detected as described below. The
percentage BrdU-positive cells in the 1-h pulse study thus repre-
sents the percentage cells in S phase between the first and the
second days of culture, while the 24-h labeling study indicates the
total fraction of replicating cells.
Apoptotic cell death was studied via the TUNEL assay. Somites
I–IV from stage 10–11 embryos were cultured in BSM plus various
growth factors. After 24 h, cultures were fixed in 4% (w/v)
paraformaldehyde and apoptotic cells were detected by the Dead
End Colorimetric Apoptosis Detection System (TUNEL assay)
from Promega.
Immunohistochemistry. As an indication of myogenic differ-
entiation, fixed cultures were stained for MyHC using the MF20
monoclonal antibody (Bader et al., 1982) as previously described
Stern et al., 1995), except that 2% nonfat dry milk was used as a
blocking agent. Cells were counted as MyHC-positive cells only if
they stained intensely brown. Proliferating cells were detected via
BrdU staining as described by Foster et al. (1987). After 4% (w/v)
araformaldehyde fixing, DNA was denatured by exposure to 2 N
Cl for 40 min, rinsed in PBS, preincubated in 2% nonfat milk, and
hen incubated with mouse anti-BrdU antibody (1:2000) which was
indly provided by S. J. Kaufman (George-Weinstein et al., 1993).
he secondary staining process employed the Vectastain ABC-AP
it (Vector Laboratories).
RT-PCR assay. Neural tube, segmental plate, or single somites
ere dissected from stage 10–14 embryos and placed immediately in
rizol Reagent (Gibco BRL). Glycogen was added as a carrier (30 mg
RNase-free glycogen; Boehringer Mannheim) and RNA was isolated
according to the manufacturer’s directions. RNA was subsequently
primed with oligo(dT) followed by cDNA synthesis using Superscript
II reverse transcriptase (Gibco BRL). One-tenth of the cDNA was
amplified in a 50-ml reaction using Advantage cDNA Polymerase Mix
Clontech) with the addition of 0.1 mCi [a-32P]dATP. After an initial
enaturation step of 94°C for 4 min, the reactions were cycled
etween 94 (1 min), 64 (1 min), and 72°C (1 min) in a Stratagene
obocycler. cDNAs for the insulin and IGF-I receptors were amplified
or 37 cycles, those for IGF-I, IGF-II, and insulin were amplified for 40
ycles, and that of S6 ribosomal protein was amplified for 30 cycles. S6
s ubiquitously expressed and served as a positive control. The
ollowing primers were used: for insulin, IGF-I, and IGF-I receptor,
oth primer pairs were exactly as described by Serna et al. (1996). For
GF-II, nucleotides 150 –160 in exon 1 1 1–13 in exon 2,
9-CTTCTACTTCAGTAGACCAGTGGG-39, and nucleotides
22–945, 59-GCGTGAGATGGCTTCTGGAAGCTC-39; for insulin
eceptor, nucleotides 94–117, 59-CTGCGGGAGCGCATTGAG-
TCCTC-39, and nucleotides 261–284, 59-CGACCAGGGTTAT-
CTCAGCGTCG-39; and for S6 ribosomal protein, nucleotides 299–
17, 59-CGCAAGTCTGTTCGGGGTT-39, and nucleotides 678–696,
59-TCCTGGCGTTTTTCCTTGG-39, were used.
One-third of the PCR was run on a 6% polyacrylamide gel, dried,
and exposed to X-ray film at 220°C for 2–16 h. The expected
product sizes are as follows: insulin, 323 bp; IGF-I, 209 bp; IGF-I
receptor, 197 bp; IGF-II, 203 bp; insulin receptor, 191 bp; and S6,
398 bp. In all cases, PCR amplification was shown to be dependent
on reverse transcription of RNA template. The identity of each
product was confirmed by restriction enzyme digests.
Statistics. Statistical analysis of differences was performed by
the Student t test for two independent variables using Microsoft
Excel 97.
s of reproduction in any form reserved.
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192 Pirskanen, Kiefer, and HauschkaRESULTS
Induction of Somite Myogenesis by IGFs
and Insulin
To study effects of insulin and IGFs on muscle devel-
opment, uncommitted somites I–III/IV from stage 13–14
embryos were cultured for 3 days in BSM with varying
concentrations of insulin, IGF-I, or IGF-II. Each factor
FIG. 1. In vitro somite myogenesis in response to defined factors
SM (A) or in BSM plus insulin (B), IGF-I (C), IGF-II (D), bFGF 1 TG
or MyHC. Concentrations of defined factors were 40 ng/ml insulipromoted substantial myogenesis (MyHC-positive cells) w
Copyright © 2000 by Academic Press. All rightompared to somites cultured in BSM alone (Fig. 1,
ompare BSM (A) to BSM 1 insulin (B), BSM 1 IGF-I (C),
nd BSM 1 IGF-II (D)). Dose–response curves for each
actor were carried out with both somite and segmental
late explants prior to the present set of studies. Each
actor promoted myogenesis in a dose-dependent manner;
ifferentiation was induced by IGF-I and IGF-II levels as
ow as 0.1 ng/ml and by insulin levels as low as 1 ng/ml,
ite III explants from stage 13 embryos were cultured for 3 days in
(E), or IGF-I 1bFGF 1 TGF-b1 (F) and were then fixed and stained
F-I, and IGF-II; 30 ng/ml bFGF; and 10 ng/ml TGF-b1.. Som
F-b1hile maximal muscle differentiation was induced by
s of reproduction in any form reserved.
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193IGF–Shh Synergy in Somite Myogenesislevels 10- to 100-fold higher. Factor concentrations for
subsequent studies were selected so as to be in the
midrange of doses giving an optimal myogenic response
(e.g., IGF-I was typically used at 40 ng/ml). The only
conditions under which all three factors exhibited addi-
tive effects were concentrations below their optimal
levels, e.g., in the 1 ng/ml range (data not shown).
IGF-I, bFGF, and TGF-b1 Act Synergistically to
Enhance the Myogenic Response in Somites and
Segmental Plate
Stern et al. (1997) showed that the combination of bFGF
nd TGF-b1 has strong myogenic promoting activity on
uncommitted somites and segmental plate, while either
factor alone has little to no myogenic promoting activity.
To determine whether IGF-I signals can interact with those
from bFGF and TGF-b1 to promote myogenesis, paraxial
esoderm explants from stage 10–11 and 13–14 embryos
ere cultured with various combinations of these growth
actors (Figs. 1E and 1F, Table 1). Uncommitted somites
somites I–III/IV) exhibited significant developmental dif-
erences in their myogenic response to IGF-I with and
ithout the simultaneous presence of bFGF and TGF-b1
(Table 1). Most somites from stage 10–11 embryos exhib-
ited no myogenic response to IGF-I, bFGF, or TGF-b1 when
nly one or two of the factors were present, and only about
TABLE 1
Stage-Dependent Differences in Somite Myogenesis in Response t
Treatmenta
Stage 10–11 embryos
Somite I–IVb Somite V–VIII
MyHC1
explants (%)d
MyHC1
cellse
MyHC1
explants (%)d
My
c
BSM, control 0 — 27 9 6
IGF-I 4 12* 76** 39 6
bFGF 0 — 29 2 6
TGF-b1 4 1 42 7 6
bFGF 1 TGF-b1 0 — 27 31 6
IGF-I 1 bFGF 8 20 6 12* 46 44 6
IGF-I 1 TGF-b1 0 — 64* 19 6
IGF-I 1 bFGF 1
TGF-b1
29 18 6 7* 68** 45 6
a Somites were cultured in BSM alone or in BSM plus defined fac
nd TGF-b1 (10 ng/ml).
b Somites I–IV from stage 10–13 and somites I–III from stage 14
c Somites V–VIII from stage 10–11 and 13–14 embryos contain i
d Percentage of cultures with at least one MyHC-positive cell whe
t least 24 different cultures were examined for each set of condit
.05, **P , 0.01, and ***P , 0.001.
e Number of MyHC-positive cells in MyHC-positive culture(s); m
positive culture. Statistical difference indicated as above.0% responded when all three factors were present. In b
Copyright © 2000 by Academic Press. All rightontrast, 50% of the uncommitted somites from stage
3–14 embryos exhibited MyHC-positive cells in the pres-
nce of IGF-I alone, and virtually all of the somites exhib-
ted high numbers of differentiated muscle cells in the
resence of all three factors. At both developmental stages
greater percentage of older somites (V–VIII) also exhibited
yHC-positive cells in the presence of IGF-I alone, and the
ean number of these cells was significantly enhanced by
he presence of all three factors. Interestingly, with older
omites from stage 13–14 embryos the simultaneous pres-
nce of bFGF and TGF-b1 consistently increased the myo-
genic response over that to IGF-I alone, while the addition
of either single factor to medium containing IGF-I was often
inhibitory to myogenic differentiation relative to that with
only IGF-I. Analogous studies with IGF-II and insulin plus
or minus bFGF and TGF-b1 gave qualitatively similar
esults.
The myogenic response of stage 10–11 and 13–14 seg-
ental plate explants to IGF-I was qualitatively similar to
hat of uncommitted somites. For example, 4 and 32% of
he rostral segmental plate explants from stages 10–11 and
3–14, respectively, exhibited MyHC-positive cells in the
resence of IGF-I, and 42 and 71% of caudal segmental plate
xplants from these stages exhibited a myogenic response
o IGF-I (data not shown). The greater myogenic response of
audal than rostral segmental plate was observed previously
hen these regions were cultured with neural tube or
-I, bFGF, and TGF-b1
Stage 13–14 embryos
Somite I–III/IVb Somite V–VIIIc
MyHC1
explants (%)d
MyHC1
cellse
MyHC1
explants (%)d
MyHC1
cellse
0 — 73 13 6 2
50*** 28 6 9* 100** 47 6 10**
15* 3 6 1* 79 23 6 6
10 1 6 0* 58 14 6 4
54*** 14 6 4** 77 21 6 6
45*** 12 6 3** 67 19 6 3
10 1 6 0* 83 12 6 2
* 95*** 53 6 10*** 100** 110 6 16***
t the following concentrations: IGF-I (40 ng/ml), bFGF (30 ng/ml),
ryos contain no cells which are committed to myogenesis.
sing numbers of cells already committed to myogenesis.
ge 10–14 explants were cultured in BSM and the indicated factor(s).
Statistical differences between control and treated cultures: *P ,
6 SEM is reported for all treatment conditions with more than oneo IGF
c
HC1
ellse
5
10*
1
2
17
14*
8
10*
tors a
emb
ncrea
n sta
ions.
eanFGF 1 TGF-b1 (Stern et al., 1997). Caudal segmental plate
s of reproduction in any form reserved.
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194 Pirskanen, Kiefer, and Hauschkaexplants also exhibited a weak myogenic response to IGF-II
and insulin. The combination of IGF-I with bFGF 1 TGF-b1
increased the percentage of MyHC-positive caudal and
rostral explants from stage 10–11 to about 30% and from
stage 13–14 to nearly 80%. Thus some paraxial mesoderm
cells that are not destined to form somites for an additional
12 h are responsive to myogenic induction by insulin and
the IGFs alone; but these factors can also act synergistically
with bFGF 1 TGF-b1 to increase the percentage of differ-
entiated muscle cells.
Considering the complete set of stage 10–11 and 13–14
data, it is clear that myogenesis can be induced in some
somite and segmental plate cells by insulin, IGF-I, or IGF-II
alone, but that IGF-I is the most potent inducer. It is also
evident that myogenic induction by these factors is en-
hanced by the simultaneous presence of bFGF 1 TGF-b1.
hese data suggest that the optimal induction of somite
yogenesis involves an interplay of multiple signals.
Are Insulin and IGFs and Their Receptors
Expressed in Early Chicken Embryos,
Neural Tubes, and Somites?
To address the possibility that insulin, IGF-I, and IGF-II
may affect myogenic development in vivo as components of
neural tube and/or somite-derived signals, we investigated
whether their mRNAs are present in stage 10–14 neural
tubes and uncommitted somites. RT-PCR analysis showed
that mRNA encoding insulin and IGF-II is present in both
the neural tube and the somites (Fig. 2), and while IGF-I
mRNA was not detected in these tissues, it was found in
FIG. 2. RT-PCR detection of IGF-I, IGF-II, insulin, IGF-I receptor,
and insulin receptor mRNAs in neural tube (n.t.) and somites I–IV
(I–IV) from stage 10–14 embryos and detection of IGF-I mRNA in
whole stage 13 embryos (c.e.). IGF-II, insulin, IGF-I receptor, and
insulin receptor transcripts were detected in both the neural tube
and somites I–IV, whereas IGF-I mRNA was not detected in
somites or neural tube, but was detected in whole embryos. All
samples contained amplifiable S6 ribosomal protein transcripts
(data not shown). Abbreviations: IGF-IR, IGF-I receptor; Ins. R.,
insulin receptor.whole stage 13 embryos. This concurs with previous stud- s
Copyright © 2000 by Academic Press. All righties which reported IGF-I mRNA in the head portion of 2-day
chick embryos (Perez-Villamil et al., 1994). To determine
whether somites could potentially respond to these ligands,
we also looked for expression of mRNAs encoding the
insulin and IGF-I receptors in the somites of stage 10–14
embryos. (Both of these receptors bind insulin, IGF-I, and
IGF-II, albeit with varying affinity.) Insulin receptor and
IGF-I receptor transcripts were found in somites as well as
in the neural tube (Fig. 2). Therefore mRNAs encoding
insulin, IGF-II, and their receptors are present in the appro-
priate embryonic tissue locations to permit their encoded
proteins to participate in the myogenic signaling pathway.
Moreover, IGF-I has been demonstrated to signal in a
paracrine fashion (Florini et al., 1996). Thus, while its
ynthetic site is not localized adjacent to paraxial meso-
erm, the possibility of IGF-I participating in early myogen-
sis is supported by detection of its mRNA in whole
mbryos at stages in which somites express IGF-I receptor
ranscripts and in which in vitro studies demonstrate
omite myogenic responsiveness to IGF-I.
Are Insulin/IGFs and Their Receptors Involved in
Myogenic Induction of Somites by the Neural
Tube?
When somites I–IV from stage 10–11 embryos are cocul-
tured with neural tube, they survive and exhibit myogen-
esis in a CEE-free BSM. As shown in Table 2, 94% of
cultures responded to neural tube induction with an aver-
age of 60 6 7 MyHC-positive cells. To determine whether
insulin or IGF-mediated signals are involved in neural
tube-induced somite myogenesis, neural tube–somite co-
cultures were exposed to antisera against these factors.
Neutralization experiments were performed in CEE-free
BSM so that the presence of unknown factors would not
complicate the analysis. Anti-IGF-I, anti-IGF-II, and anti-
insulin antibodies were used at concentrations capable of
blocking myogenic induction effects of IGF-I, IGF-II, and
insulin on somites when present at 20 ng/ml. Addition of
goat anti-IGF-II or anti-insulin antibodies to the BSM de-
creased the MyHC-positive cell number from 60 6 7 to
39 6 6 (P , 0.05) and 32 6 5 (P , 0.01), respectively,
hereas addition of equivalent amounts of nonimmune
oat IgG had no effect on myogenesis (Table 2). A combi-
ation of anti-insulin and anti-IGF-II antibodies decreased
yHC-positive cultures to 42% (P , 0.001) and the
verage number of MyHC-positive cells to 15 6 4 (P ,
.001). As anticipated, because neural tubes do not express
GF-I, anti-IGF-I antibody alone did not block neural tube-
nduced myogenesis, and it did not increase blocking effects
f anti-insulin and anti-IGF-II antibodies on neural tube–
omite cocultures (Table 2). These data suggest that insulin
nd IGF-II could be involved in neural tube-mediated sig-
als for somite induction, whereas any involvement of
GF-I would have to be via systemic sources. This is
onsistent with our finding that insulin and IGF-II tran-
cripts are present in the neural tube while those of IGF-I
s of reproduction in any form reserved.
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195IGF–Shh Synergy in Somite Myogenesisare absent from the neural tube but present in whole
embryos.
IGF-I receptor and insulin receptor are both signal trans-
ducers for IGF-I, IGF-II, and insulin (Florini et al., 1996).
When neural tube–somite cocultures were treated with
anti-IGF-I receptor or anti-insulin receptor antibodies that
block receptor function, fewer MyHC-positive cells were
observed (20 6 4, P , 0.001, and 11 6 3, P , 0.001,
espectively, versus 60 6 7 without antibodies), whereas
ontrol cultures treated with equivalent amounts of non-
mmune rabbit IgG exhibited no significant decrease in
yHC-positive cells (Table 2). These data imply that both
he insulin and the IGF receptors transduce neural tube
ignals which promote somite myogenesis.
Induction of Somite Myogenesis by Shh
Comparison of the maximal myogenic induction of un-
TABLE 2
Effects of Anti-insulin, Anti-IGF-I, Anti-IGF-II, and Anti-IGF
Receptor and Anti-insulin Receptor Blocking Antibodies on
Myogenic Induction by the Neural Tube
Tissue Antibody n
MyHC1
explants (%)a
MyHC1 cells
(mean 1 sem)b
Somite I–IV 1
neural tubec
None 32 94 60 6 7
Anti-IGF-I 16 100 70 6 7
Anti-IGF-II 16 100 39 6 6*
Anti-insulin 24 88 32 6 5**
Anti-IGF-II
and anti-
insulin 20 42*** 15 6 4***
Anti-IGF-I 1
anti-IGF-II
1 anti-
insulin 16 44*** 20 6 7***
Anti-IGF
receptord 10 79 20 6 4**
Anti-insulin
receptor 10 75 11 6 3**
Goat IgGe 16 94 67 6 12
Rabbit IgGf 37 80 53 6 10
a Percentage of cultures with at least one MyHC-positive cell.
tatistical differences between control and antibody-treated cul-
ures: * P , 0.05, ** P , 0.01, and *** P , 0.001.
b Number of MyHC-positive cells in MyHC-positive culture(s).
esults represent means 6 SEM. Statistical difference indicated as
bove.
c Neural tube pieces were cocultured with somites I–IV from
stage 10–11 embryos in BSM without CEE.
d Previous control studies with irrelevant mouse monoclonal
ntibodies showed no effects on neural tube-induced somite myo-
enesis (Stern et al., 1997; Table 4, line C).
e Control for anti-IGF-I and anti IGF-II antisera.
f Control for anti-insulin receptor antiserum.committed somites from stage 10–11 embryos by IGF-I 1
Copyright © 2000 by Academic Press. All rightFGF 1 TGF-b1 (Table 1) to that of somites cocultured with
neural tube (Table 2) indicates that the neural tube stimu-
lates about threefold more cells to become MyHC-positive.
This implies that the neural tube may supply components
other than insulin/IGF-II and bFGF. (Previous antisera in-
hibition studies showed that TGF-b1 was not a component
of neural tube-mediated somite myogenesis; Stern et al.,
1997.) Earlier studies by our group and others suggested
involvement of both the Wnts and Sonic hedgehog (Stern et
al., 1995; Mu¨nsterberg et al., 1995; Hirsinger et al., 1997;
Borycki et al., 1998; Cann et al., 1999). Although Shh had
not been tested directly in our single-somite assay system,
previous data (Stern et al., 1997) and results from the
present studies (e.g., uncommitted somites exhibit myogen-
esis in CEE-free BSM in response to IGF-I plus bFGF
1TGF-b1) implied that in vitro myogenesis can occur
ithout Shh. Furthermore, Mu¨nsterberg et al. (1995b) dem-
nstrated that Shh alone was insufficient to induce myo-
enesis in presegmental plate mesoderm from stage 10
mbryos. However, given the unanticipated myogenic in-
uctive effects of insulin and the IGFs, the synergism of
hese with bFGF 1 TGF-b1, the higher inductive levels
achieved in neural tube cocultures than with any combina-
tion of defined factors, and the likelihood that somites
would have been exposed to Shh prior to their dissection, it
was of interest to assess Shh as an additional defined factor
that might be involved in the array of signals affecting
somite myogenesis in vitro.
The role of Shh was examined by adding Shh to uncom-
mitted somites from stage 13–14 embryos cultured in BSM.
Shh promotes substantial myogenesis by itself (Fig. 3A; see
below for BSM minus CEE). Further studies showed that the
effects of Shh were dose-dependent. Addition of 1 ml Shh-
conditioned medium to 100 ml culture BSM (;1 nM final
Shh concentration) induced myogenesis in 20% of the
explants, while about 60% of the cultures became MyHC-
positive in the presence of 5–10 ml (;5–10 nM) Shh-
conditioned medium, and about 80% of the cultures be-
came MyHC-positive in the presence of 20–30 ml (;20–30
M) Shh-conditioned medium. Higher levels of Shh did not
ause further increases in somite myogenesis. As shown
reviously by Mu¨nsterburg et al. (1995), and in contrast to
our data for insulin, the IGFs, and bFGF 1 TGF-b1, Shh
lone was not able to promote myogenesis in caudal and
ostral segmental plate cultures (data not shown).
Do IGF, bFGF, TGF-b1, and Shh Signals Interact to
Promote Myogenesis?
Synergistic effects were studied by adding different factor
combinations to uncommitted somites cultured in BSM as
well as CEE-free BSM. Somites from stage 13–14 embryos
cultured in BSM plus either IGF-I or Shh alone, or with both
factors, differentiated well in the presence of either single
factor, but exhibited the greatest myogenesis when both
factors were present (Figs. 1C, 3A, and 3B). When cultured
in CEE-free BSM, so as to preclude effects of unknown
s of reproduction in any form reserved.
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196 Pirskanen, Kiefer, and Hauschkafactors, somites appeared unhealthy and exhibited no myo-
genesis unless bFGF, insulin/IGFs, or Shh was present (Fig.
4). In CEE-free BSM, TGF-b1 (10 ng/ml) had no myogenic
inducing effect, insulin or IGF-II alone at 40 ng/ml caused
only about 5% of the explants to become myogenic (data
not shown), and bFGF alone induced low levels of myogen-
esis in only about 20% of the somites (Fig. 4). In contrast,
FIG. 3. In vitro somite myogenesis in response to Sonic hedgehog
lus other defined factors. Somite III explants from stage 13 embryo
ere cultured for 3 days in BSM plus Shh (A), Shh 1 IGF-I (B), or
Shh 1 IGF-I 1bFGF 1 TGF-b1 (C) and were then fixed and stained
or MyHC. Factor concentrations were 40 ng/ml IGF-I, 10 ml
hh-conditioned medium (;10 nM), and, for the combination of
rowth factors (GFs), 40 ng/ml IGF-I, 30 ng/ml bFGF, and 10 ng/ml
GF-b1. See Fig. 1A for comparison with no added factors.either IGF-I or Shh induced substantial myogenesis, and the a
Copyright © 2000 by Academic Press. All rightombination of IGF-I and Shh was highly synergistic; 100%
f somite cultures were myogenic with an average of 113 6
1 MyHC-positive cells (P , 0.001). The combination of
FGF, TGF-b1, and IGF-I (“GFs”) also induced myogenesis
in 100% of the somites but only about half as many cells
became MyHC-positive, and interestingly, while nearly
90% of the somites exhibited myogenesis when cultured
with all four factors (IGF-I, bFGF, TGF-b1, Shh) the number
of MyHC-positive cells per explant decreased by more than
fivefold in CEE-free BSM (Fig. 4) and by severalfold in BSM
(Fig. 3C). Taken together these data suggest that IGF-I and
Shh are strongly synergistic in promoting myogenesis, but
that their inductive effects may also be repressed at the
level of terminal differentiation by the presence of multiple
proliferation-stimulating growth factors (see below).
FIG. 4. In vitro somite myogenesis in response to the addition of
efined factors to CEE-free BSM. Somites I–III/IV from stage 13–14
chicken embryos were cultured in BSM without CEE. Concentrations
for defined factors were 40 ng/ml IGF-I, 30 ng/ml bFGF, 10 ml
Shh-conditioned medium (;10 nM), and, for the combination of the
rowth factors (GFs), 40 ng/ml IGF-I, 30 ng/ml bFGF, and 10 ng/ml
GF-b1. Results are reported as the means 6 SEM from at least 16
xplants. Statistical differences between control and treated cultures
re indicated as *P , 0.05, **P , 0.01, and ***P , 0.001.
s of reproduction in any form reserved.
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197IGF–Shh Synergy in Somite MyogenesisIGFs, bFGF, and Shh Affect Cell Survival and
Proliferation in Somite Cultures
A consistent observation in BSM assays with and without
single factor additions is that cell numbers do not increase
at the rate anticipated for growing somites, and in many
cases the original cell numbers decrease. Since cell survival
and proliferation could have major effects on myogenic
induction, these parameters were examined. Somites I–IV
FIG. 5. Effects of defined factors on apoptotic cell death in somite
After 24 h cultures were fixed and apoptotic cells (brown nuclei) we
counterstained with eosin to show nonapoptotic cells. Concentra
edium (;10 nM), and, for the combination of growth factors (GFfrom stage 10–11 embryos have 1663 6 88 cells; yet after 3 7
Copyright © 2000 by Academic Press. All rightdays culture in BSM the mean cell number per somite
culture decreased to 481 6 25, indicating extensive cell
death. When added alone IGF-I, IGF-II, insulin, bFGF, and
Shh significantly reduced cell loss (Table 3), but they did
not increase cell numbers (TGF-b1 had no effect). Further-
ore, IGF-I and bFGF together or with the further addition
f TGF-b1 supported only small increases in cell numbers.
owever, when Shh was combined with either IGF-I alone,
r with all three factors, the explant cell number increased
res. Somites I–IV from stage 10–11 embryos were cultured in BSM.
termined as described under Materials and Methods. Cultures were
s of defined factors were 40 ng/ml IGF-I, 10 ml Shh-conditioned
0 ng/ml IGF-I, 30 ng/ml bFGF, and 10 ng/ml TGF-b1.cultu
re de- and 10-fold, respectively.
s of reproduction in any form reserved.
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198 Pirskanen, Kiefer, and HauschkaTo determine whether proliferation was occurring under
culture conditions in which cell numbers declined, ex-
plants were treated with 100 mM BrdU for 1 h starting at
3 h and were then fixed and stained for BrdU as an
ndication of cells in S phase (Table 3). Only about 4% of
uclei in control cultures stained for BrdU (Table 3),
hereas the addition of 40 ng/ml IGF-I, IGF-II, or insulin;
hh (10 ml, ;10 nM); or bFGF (30 ng/ml) all increased the
S-phase-positive nuclei to about 10%. As anticipated from
the cultured somite cell counts (Table 3), the combination
of IGF-I and Shh increased cell proliferation further so that
27.5% of nuclei were BrdU-positive, while 35% of the cells
were in S phase in media containing Shh, IGF-I, bFGF, and
TGF-b1. When cultures containing all of these factors were
ncubated continuously with 10 mM BrdU between 24 and
48 h and then fixed, greater than 95% of the cells were
TABLE 3
Somite S-Phase Cells at 24 h in Vitro and Total Cell Numbers
fter 3-Day Exposure to Defined Factors
Condition
% cells in S phase
at 24 ha
Mean cell number
at 3 daysb
Noncultured control N.D. 1660 6 90
BSM, no added factors 3.7 6 0.4 480 6 20
IGF-I 11.3 6 1.2c 1010 6 90c
IGF-II 11.0 6 0.8c 990 6 70c
Insulin 9.1 6 1.1c 600 6 20c
bFGF 10.3 6 0.9c 1240 6 60c
TGF-b1 3.8 6 0.2 460 6 20
bFGF 1 IGF-I 18.8 6 0.8c,d 1960 6 120c,d
TGF-b1 1 IGF-I 10.0 6 0.9c 970 6 50c
bFGF 1 TGF-b1 1 IGF-I 19.4 6 0.7c,d 2864 6 397c,d
Sonic hedgehog (Shh) 12.5 6 0.9c 1090 6 100c
Shh 1 IGF-I 27.5 6 1.5c,d 11950 6 1100c,d
Shh 1 bFGF 1 TGF-b1
1 IGF-I 35.0 6 2.8c,e 16940 6 1490c,e
a Somites I–IV from stage 11 embryos were cultured in BSM
lone or BSM plus defined factors for 23 h. Factor concentrations
ere the following: 40 ng/ml IGF-I, 40 ng/ml IGF-II, 40 ng/ml
nsulin, 30 ng/ml bFGF, 10 ng/ml TGF-b1, and 10 ml Sonic
hedgehog-conditioned medium (;10 nM). BrdU was then added to
the culture medium at a final concentration of 100 mM for the final
h of culture. The cultures were fixed and stained for incorporated
rdU as described under Materials and Methods. Percentages are
eans 6 SEM from at least 12 different explants.
b Somites I–IV from stage 10–11 embryos were utilized for cell
ount experiments. After 3 days of culture explants were
rypsinized and the cells counted by a hemacytometer. Cell num-
ers are means 6 SEM from at least 12 different somites subjected
o each culture environment.
c Statistical difference between the BSM control and factor-
treated cultures P , 0.001.
d Statistical difference between the cultures with IGF-I plus a
ingle additional factor and IGF-I alone P , 0.001.
e Statistical difference between mean cell number in cultures
with Shh 1 bFGF 1 TGF-b1 1 IGF-I and Shh 1 IGF-I P , 0.01.BrdU-positive, indicating that nearly all cells replicated at
Copyright © 2000 by Academic Press. All righteast once during this period. Explants exposed to BrdU for
4 h without added factors exhibited only 5% BrdU-positive
ells.
To study whether these factors also affect cell apoptosis,
omites I–IV from stage 10–11 embryos were cultured for
4 h either with or without different factors and then
ubjected to TUNEL assays. Apoptosis was observed under
ll conditions studied, and most apoptotic cells were seen
n the center of the spreading explants. Compared to control
ultures, apoptotic cells were decreased at least twofold by
he presence of any single factor, except TGF-b1 (Figs. 5A,
B, and 5C). Media with either Shh 1 IGF-I or bFGF 1
GF-b1 1 IGF-I or with all four factors caused at least
nother twofold decrease in apoptotic cells (Figs. 5D, 5E,
nd 5F). (Precise numerical analysis of apoptosis could not
e performed since apoptotic cells were often located in the
enters of explants where cell density is too great for
ccurate counting.) Taken together the BrdU-labeling and
UNEL assays indicate that insulin, the IGFs, and Shh
timulate somite cell proliferation and decrease somite
poptotic cell death. In both cases the insulin/IGF factors
ct synergistically with Shh as well as with bFGF 1
GF-b1.
DISCUSSION
Skeletal muscle development is regulated by multiple
polypeptide factors. Wnts, Shh, bFGF, and possibly a
TGF-b1 family member play roles in the initial induction of
omite myogenesis (Mu¨nsterberg et al., 1995a,b; Du et al.,
997; Fan et al., 1997; Stern et al., 1995, 1997; Borycki et al.,
1998, 1999), while FGFs, TGF-b1, IGF-I, and many other
itogenic factors control muscle differentiation by stimu-
ating proliferation and repressing the onset of terminal
ifferentiation (Linkhart et al., 1981; Lathrop et al., 1985;
legg et al., 1987; Seed and Hauschka, 1988; Florini and
agri, 1989; Campbell et al., 1995; Weyman and Wolfman,
998), and insulin, IGF-I, and IGF-II, and possibly TGF-b1
increase the level of differentiation (Florini et al., 1996;
Zentella and Massaque, 1992). Given that insulin and the
IGFs can affect the onset of muscle differentiation as well as
the extent of postdifferentiation muscle development, we
sought to determine whether they were also involved in the
initial induction of somite myogenesis and, if so, whether
they acted synergistically with other known myogenic
inducers.
Insulin and the IGFs were tested for myogenic inducing
effects using single somite/segmental plate explants (Stern
and Hauschka, 1995). Addition of insulin, IGF-I, or IGF-II to
BSM promoted somite/segmental plate myogenesis in a
dose-dependent manner while control contralateral ex-
plants exhibited no myogenic differentiation during a 3-day
culture period in BSM; IGF-I also promoted myogenesis in
BSM minus CEE. Insulin and IGFs were also able to
synergistically promote muscle development with bFGF
1TGF-b1 (Fig. 1, Table 1) or with Shh (Figs. 3 and 4).
s of reproduction in any form reserved.
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199IGF–Shh Synergy in Somite MyogenesisInterestingly, bFGF or TGF-b1 did not exhibit synergism
ith Shh alone (data not shown), and when these two
actors were added to BSM containing the otherwise highly
otent IGF-I 1 Shh combination, the number of MyHC-
ositive cells was diminished (Fig. 4). While this could be
ue to an inhibition of myogenic induction per se, it could
lso be due to a secondary repression of terminal differen-
iation among cells that had been induced to enter the
yogenic lineage. An analogous “induction/repression”
henomenon was described previously for FGF-dependent
uscle colony-forming cells in developing chick limb buds
Seed and Hauschka, 1988). In contrast to the inducing
actor synergisms described above, when IGF-I and Wnt-1
ere combined by adding IGF-I to somites cultured on
at-2 cells expressing Wnt-1 (Stern et al., 1995), no syner-
gism was observed (data not shown). This result does not,
however, preclude the possibility of interactions between
the IGF-I and the Wnt signal transduction pathways in vivo,
because analysis of Wnt effects in our assay system is
complicated by inhibitory effects of the Rat-1 cell mono-
layer (see Fig. 6 in Stern et al., 1995).
Our study also examined the neural tube and somites for
mRNAs encoding IGF-I, IGF-II, insulin, and their receptors
to determine whether these components were present in
the appropriate interacting tissues in vivo. mRNAs for
insulin and IGF-II and for the insulin and IGF receptors
were present in the neural tube and somites of stage 13–14
embryos (Fig. 2) and, although IGF-I transcripts were not
found in either tissue, IGF-I mRNA was detected in whole
stage 13–14 embryos. Thus insulin and IGF-II could be
secreted by the neural tube or produced endogenously by
somites, and IGF-I could be available systemically. Other
investigators have also detected mRNAs for insulin, IGF-I
and their receptors in early chick embryos (Perez-Villamil
et al., 1994; Holzenberger et al., 1996; Morales et al., 1997),
and in situ hybridization analyses indicate widespread
distribution of preproinsulin mRNA in a pattern similar to
that of insulin receptor mRNA beginning from the blasto-
derm stage (Perez-Villamil et al., 1994; Morales et al., 1997).
In situ hybridization studies of stage 13–14 embryos have
also revealed high levels of IGF receptor mRNA in the
neuroepithelia, notochord, and somites (Holzenberger et
al., 1996); biologically active insulin has been detected in
2-day-old chick embryos as well as in the yolk of unfertil-
ized eggs (De Pablo et al., 1982), and yolk has also been
shown to contain IGF activity (Scavo et al., 1989).
Combining our RT-PCR results with data from the above
studies suggests that the IGFs, insulin, and their receptors
almost certainly exhibit a temporal and spatial occurrence
which would be appropriate for their participation as com-
ponents of the in vivo somite myogenic induction process.
However, a complexity raised by our studies concerns why
somites which are expressing insulin and IGF-II mRNAs
nevertheless require addition of these ligands to the BSM in
order to undergo myogenesis in vitro. An analogous para-
doxical situation occurs in certain myoblasts which synthe-
Copyright © 2000 by Academic Press. All rightsize bFGF but nevertheless require exogenous FGF in order
to replicate (Hannon et al., 1996).
Further evidence for normal developmental roles of insu-
lin and the IGFs in these early phases of muscle develop-
ment was obtained by treating neural tube–somite cocul-
tures with antibodies to either the ligands or their
receptors. Neural tube-mediated somite myogenesis was
diminished upon the addition of anti-insulin, anti-IGF-II,
anti-insulin receptor, or anti-type I-IGF receptor antibodies
(Table 2). Together, these results are consistent with the
hypothesis that insulin and IGF-II produced by the neural
tube or somites are involved in early somite myogenesis.
Although anti-IGF-I antibody did not diminish neural tube-
induced myogenesis in vitro, this is not surprising since
IGF-I transcripts were not detected in the neural tube; the
antisera inhibition data thus do not exclude the in vivo
involvement of systemic IGF-I.
While our in vitro studies as well as the in vivo IGF/
insulin/receptor distribution studies summarized above are
consistent with the IGFs and insulin playing myogenic
inductive roles in vivo, data from in vivo somite/neural
ube manipulation studies raise additional interpretive
omplexities. Namely, somites that remain in place follow-
ng neural tube removal (Rong et al., 1992), and segmental
lates that have been spatially displaced from their normal
lose proximity to the neural tube/notochord (Borycki et
l., 1998), do not exhibit myogenesis, despite the fact that
uch somites should still be exposed to any systemically
vailable and endogenously synthesized IGFs and insulin
Fig. 2). Systemic/endogenous IGFs and insulin are thus not
ufficient to induce somite myogenesis in vivo under these
xperimental conditions. The absence of myogenesis could
e due to insufficient levels of these ligands, as well as to an
mbalance of positive and negative factors (e.g., Hirsinger et
l., 1997) at the abnormal position in which the somites are
laced.
In vitro analysis of somite myogenesis is also compli-
ated by effects of the culture environment on cell survival
nd replication (Table 3 and Fig. 5). Evidence that some
omite cells die in BSM was obtained by direct cell counts
fter 3 days in vitro and by TUNEL assays. These studies
ndicated that significant cell death occurred under all
onditions in which only a single putative myogenic induc-
ng factor was added to the BSM and even when some
yogenic differentiation was promoted, as in the cases of
GF-I or Shh. However, when IGF-I and Shh were combined
ith each other and/or with bFGF 1 TGF-b1, the total cell
number in somite explants increased and fewer apoptotic
cells were detected. To determine whether proliferation
occurred under the conditions in which extensive cell death
was observed, cultures were pulse-labeled with BrdU to
assess the percentage of S-phase cells. In agreement with
previous data (Florini et al., 1996; Massague´, 1998;
Tajbakhsh and Spo¨rle, 1998), we found that insulin, IGF-I,
IGF-II, bFGF, and Shh stimulated somite cell proliferation,
while TGF-b1, alone, had no effect. IGF-I, Shh, and bFGF
were roughly equivalent inducers of somite cell prolifera-
s of reproduction in any form reserved.
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200 Pirskanen, Kiefer, and Hauschkation (Table 3); however, IGF-I and Shh were each consider-
ably more potent than bFGF in increasing the number of
MyHC-positive cells (Table 1, Fig. 4). This implies that the
myogenic inducing effects of IGF-I and Shh are not solely
attributable to an increase in cell proliferation.
The mechanistic similarities between insulin/IGF effects
during somite myogenesis and during terminal differentia-
tion and muscle hypertrophy are unknown. Many in vitro
studies have demonstrated positive myogenic effects of
insulin and the IGFs (Florini et al., 1986, 1996; Damon et
l., 1998). For example, insulin, IGF-I, or IGF-II alone
otentiate differentiation of L6 rat myogenic cells (Minotti
t al., 1998), and inhibition of IGF-II expression in C2
ouse myoblasts abolishes their ability to undergo autono-
ous differentiation (Montarras et al., 1996). Furthermore,
hicken myoblasts from 11- to 12-day embryos undergo
oth cell hyperplasia and myofiber hypertrophy in response
o insulin and IGF-I, while IGF-II stimulates only cell
yperplasia (Vandenburgh et al., 1991). In addition, mouse
ene knockout studies of IGF-I, IGF-II, and IGF receptor
ndicate severe decreases in muscle mass and significant
ffects on muscle development (Baker et al., 1993; Powell-
raxton et al., 1993). In contrast, IGF-I overproduction in
ransgenic mice after the onset of terminal muscle differ-
ntiation causes muscle hypertrophy (Barton-Davis et al.,
998; Musaro et al., 1999).
The effects of insulin and IGFs on cell proliferation and
ifferentiation of muscle cells from later developmental
tages are mediated by both the mitogen-activated protein
MAP) kinase and phosphatidylinositol 3 (PI3) kinase cas-
ades (Florini et al., 1996; Kaliman et al., 1996, 1998;
Gredinger et al., 1998; Weyman and Wolfman, 1998). Inter-
estingly, one downstream target of the MAP kinase/PI3
kinase-mediated insulin/IGF signals is p300/CBP (Klemm
et al., 1998), which in transactivation studies is known to
function as a coactivator of both MyoD and MEF2C (Sar-
torelli et al., 1997) and which may affect myogenesis via its
association with PCAF histone acetyltransferase (Puri et
al., 1997; Sartorelli et al., 1999). Perhaps these pathways are
also used for controlling early events in myogenic determi-
nation.
The differentiation of older myoblasts in response to IGF
can occur in the absence of proliferation (Turo and Florini,
1982; Florini et al., 1986). Similarly, the increase in MyHC-
positive cells after treating somite cultures with growth
factors was not directly correlated with increased cell
numbers (compare values in Tables 1 and 3, e.g., IGF-I vs
bFGF for somites I–III/IV). However, we cannot rule out the
possibility that these factors stimulate myogenesis by se-
lectively increasing the survival of cells that had already
become committed to myogenesis. The same interpretive
complexity applies to the mechanism of Shh, a widely
accepted “inducer” of somite myogenesis.
Our studies indicate that Shh has a potent effect upon
somite cell proliferation and survival when combined with
IGF-I, bFGF, and TGF-b1 (Table 3 and Fig. 5). These data are
onsistent with the hypothesis that a major component of
Copyright © 2000 by Academic Press. All righthh’s positive effects on somite myogenesis involves
timulating cell proliferation and/or inhibiting cell death;
ut we have no direct evidence proving that the affected
ells are myogenic precursors. Working with more devel-
ped somites, Cann et al. (1999) have also shown that Shh
timulates cell proliferation and prevents apoptosis; but in
ddition they discovered that Shh potentiates the develop-
ent and/or survival of cells that become primary slow-
ype muscle fibers. In vivo studies also suggest multiple
hh effects on myogenesis. Du et al. (1997) reported that
ctopic Shh expression induced slow muscle precursors
hroughout the zebrafish somite; Teillet et al. (1998) found
hat the survival of somite myogenic and chondrogenic cell
ineages is mediated by Shh; Borycki et al. (1999) reported
hat Shh is required for sclerotomal cell survival but is not
ssential for the survival or proliferation of epaxial myo-
enic precursor cells; Marcelle et al. (1999) proposed that
itogenic effects of Shh mediate the selective expansion of
ubpopulations within developing somites. Similarly, Shh
nd Wnt signals compete in the specification of presomitic
esoderm to become sclerotome or dermamyotome (Lee et
l., 2000). Taken together these studies indicate that Shh
ediates a broad spectrum of processes in somite develop-
ent which impinge upon proliferation, cell survival, and
ifferentiation. How these processes affect myogenic induc-
ion remains to be determined.
The relationship of MyoD and Myf5 gene expression to
yogenic induction is not fully understood. While these
enes have been described as “activated” in response to
yogenic inducing tissues and factors (Mu¨nsterberg et al.,
995b; Borycki et al., 1999), they are, in fact, expressed in
both the epiblast and the paraxial mesoderm prior to the
time at which intact somites exhibit cells committed to
myogenesis. For example, MyoD and Myf5 mRNAs are
detected by RT-PCR assays prior to somite segmentation in
both mouse and chick (Kopan et al., 1994; Mu¨nsterberg et
al., 1995b; Lin Jones and Hauschka, 1996; George-
Weinstein et al., 1996; J. Kiefer and S. D. Hauschka,
unpublished). However, MyoD and Myf5 gene expression is
reduced to undetectable levels in somites cultured without
inducing factors (Mu¨nsterberg et al., 1995b; J. Kiefer and
S. D. Hauschka, unpublished) or when the neural tube
and/or notochord are removed from chick embryos (Teillet
et al., 1998) or when somites/segmental plates are physi-
cally separated from proximity to the neural tube/
notochord in vivo (Pownall et al., 1996; Spence et al., 1996;
Borycki et al., 1998). These observations indicate that the
initial expression of Myf5/MyoD is not sufficient to main-
tain somite myogenesis either in vivo or in vitro if the
inducing components are withdrawn. Defined factors such
as Wnts, Shh, bFGF1TGF-b1, and insulin/IGFs might thus
unction as “permissive” as well as de novo “inductive”
signals.
In conclusion, insulin and the IGFs have been shown to
promote/induce somite myogenesis in vitro, to increase
somite cell proliferation, to decrease apoptosis, and to be
synthesized at the correct times and places to affect all of
s of reproduction in any form reserved.
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201IGF–Shh Synergy in Somite Myogenesisthese activities. Since insulin and IGFs are able to synergize
in vitro with other factors, bFGF 1 TGF-b1 and Shh, to
romote even higher levels of somite muscle formation,
ell proliferation, and inhibition of apoptosis, the entire set
f factors may play similar roles in vivo, even if some are
ot the primary muscle-inducing signals. Identifying pri-
ary and secondary gene targets of the multiple signal
ransduction pathways activated by these factors will be
ecessary for obtaining a full understanding of somite
yogenesis.
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